OVINTIV INC (OVV)
Sector: Energy
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Energy
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for OVV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OVV | Independent Director; Chair | 72 | ["experience in portfolio management", "asset allocation", "risk management", "thematic investing", "Chief Investment Officer (CIO) of H&S Ventures, LLC", "CEO of the University of Texas Investment Management Company (UTIMCO)", "management of $15 billion of endowment and operating funds", "board leadership experience"] | ["CRG", "HRC", "CORPORATE RESPONSIBILITY AND GOVERNANCE COMMITTEE"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Ricks brings the mindset of the institutional investor to the boardroom, sharing his experience in portfolio management, asset allocation, risk management and thematic investing. After following an unconventional path (from international banking in Asia to finance roles to high-net worth and public institution capital/wealth management), he appreciates the importance and complexity of balancing sustainability overlays with portfolio investment objectives. Mr. Ricks uses his capital management expertise to chair Ovintiv s Corporate Responsibility and Governance Committee, previously served as Chair of the Human Resource Committee, and frequently engages with shareholders, soliciting feedback on the Company s executive compensation program which is shared around the Board table. He served as Chief Investment Officer (CIO) of H&S Ventures, LLC, a Forbes 150 family office, from 2001 until his retirement in 2018. He was also CEO of the University of Texas Investment Management Company (UTIMCO), where he was responsible for the management of $15 billion of endowment and operating funds. Mr. Ricks joined the Ovintiv Board in 2019 following the acquisition of Newfield Exploration Company. He also serves as a director of Sensei Biotherapeutics, Inc., a public clinical-stage biopharmaceutical company, building upon his significant board leadership experience. CURRENT ROLES Director, Sensei Biotherapeutics, Inc. (2015-Current) EDUCATION AND CREDENTIALS MBA, University of Chicago BA, Economics, Trinity College PREVIOUS ROLES Director, Ocean Institute CIO, H&S Ventures LLC CEO, The University of Texas Investment Management Company Various leadership roles with the University of Texas System, including: Vice Chancellor, Asset Management Executive Director, Finance and Private Investments Director, Newfield Exploration Company Director, Argus Pharmaceuticals Director, LifeCell Corporation Director, BDM International Investment Advisor, University of California-Irvine Foundation Investment Advisor, St. David s Foundation SKILLS AND EXPERTISE Accounting & Finance Environment & Safety Financial Reporting Governance/ Public Company Board Experience Human Capital Management Reserves Risk Management CEO/ Sr. Officer Experience